NCT03350269

Brief Summary

The study is designed as a randomized controlled trial. The investigators hypothesize that kidney transplant recipient candidates whose donors are offered reimbursement of lost wages (treatment arm) will have a higher probability of receiving a living donor kidney transplant than those randomized to no offer of lost wage reimbursement (control arm). The study expects to demonstrate incremental living donor kidney transplants by assisting individuals who wish to be living organ donors but would be otherwise unable to do so due to the obligatory forfeit of income during the evaluation, donation surgery, and post-operative recuperation periods.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,310

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

6 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 14, 2017

Completed
1 day until next milestone

Study Start

First participant enrolled

November 15, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 22, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2020

Completed
Last Updated

January 3, 2022

Status Verified

January 1, 2020

Enrollment Period

2.6 years

First QC Date

November 14, 2017

Last Update Submit

December 13, 2021

Conditions

Keywords

Living kidney donationKidney transplantLost Wage Reimbursement

Outcome Measures

Primary Outcomes (1)

  • Effect of offering wage reimbursement on rate of living donor kidney transplant

    Number of kidney transplant recipient candidates in intervention vs. control group who receive a living door transplant within one year of their first visit to the participating transplant center for evaluation as a potential kidney transplant recipient (time zero)

    One year from time zero

Secondary Outcomes (2)

  • Difference in time to outcome events (living donor transplant, deceased donor transplant, removal from transplant waiting list, death) between control group and intervention arm

    Time zero to one year

  • Effect of offering donor wage reimbursement on demographic characteristics of living kidney donor pool

    Time zero to one year

Study Arms (2)

Intervention

EXPERIMENTAL

Kidney transplant recipient candidates who are informed that their living donor candidates can receive reimbursement for lost wages incurred during the evaluation, donation surgery and recuperation

Other: Information provision

Control

NO INTERVENTION

Kidney transplant recipient candidates who receive standard of care (donors are not offered wage reimbursement)

Interventions

Kidney transplant recipients are informed that their donors may be eligible for lost wage reimbursement

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 at enrollment
  • Meet participating transplant center standards to initiate an evaluation to receive a kidney transplant
  • Kidney-only or kidney intended to be followed by other organ (e.g. deceased donor pancreas)
  • First-time recipient candidate
  • Capable of providing informed consent

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

UCLA Kidney and Pancreas Transplant Program in collaboration with the Transplant Research and Education Center (TREC)

Los Angeles, California, 90024, United States

Location

University of Colorado

Denver, Colorado, 80045, United States

Location

Michigan Medicine - University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

Mt. Sinai Medical Center

New York, New York, 10029, United States

Location

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Related Publications (23)

  • Agerskov H, Ludvigsen MS, Bistrup C, Pedersen BD. From donation to everyday life: Living kidney donors' experiences three months after donation. J Ren Care. 2016 Mar;42(1):43-52. doi: 10.1111/jorc.12137. Epub 2015 Oct 14.

    PMID: 26463844BACKGROUND
  • Larson DB, Jacobs C, Berglund D, Wiseman J, Garvey C, Gillingham K, Ibrahim HN, Matas AJ. Return to normal activities and work after living donor laparoscopic nephrectomy. Clin Transplant. 2017 Jan;31(1). doi: 10.1111/ctr.12862. Epub 2016 Dec 22.

    PMID: 27740731BACKGROUND
  • Clarke KS, Klarenbach S, Vlaicu S, Yang RC, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network. The direct and indirect economic costs incurred by living kidney donors-a systematic review. Nephrol Dial Transplant. 2006 Jul;21(7):1952-60. doi: 10.1093/ndt/gfl069. Epub 2006 Mar 22.

    PMID: 16554329BACKGROUND
  • Waterman AD, Covelli T, Caisley L, Zerega W, Schnitzler M, Adams D, Hong BA. Potential living kidney donors' health education use and comfort with donation. Prog Transplant. 2004 Sep;14(3):233-40. doi: 10.1177/152692480401400309.

    PMID: 15495783BACKGROUND
  • Warren PH, Gifford KA, Hong BA, Merion RM, Ojo AO. Development of the National Living Donor Assistance Center: reducing financial disincentives to living organ donation. Prog Transplant. 2014 Mar;24(1):76-81. doi: 10.7182/pit2014593.

    PMID: 24598569BACKGROUND
  • Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA; KDOC Study Group. Direct and Indirect Costs Following Living Kidney Donation: Findings From the KDOC Study. Am J Transplant. 2016 Mar;16(3):869-76. doi: 10.1111/ajt.13591. Epub 2016 Feb 4.

    PMID: 26845630BACKGROUND
  • Rodrigue JR, Schold JD, Morrissey P, Whiting J, Vella J, Kayler LK, Katz D, Jones J, Kaplan B, Fleishman A, Pavlakis M, Mandelbrot DA; KDOC Study Group. Predonation Direct and Indirect Costs Incurred by Adults Who Donated a Kidney: Findings From the KDOC Study. Am J Transplant. 2015 Sep;15(9):2387-93. doi: 10.1111/ajt.13286. Epub 2015 May 5.

    PMID: 25943721BACKGROUND
  • Rodrigue JR, Schold JD, Mandelbrot DA. The decline in living kidney donation in the United States: random variation or cause for concern? Transplantation. 2013 Nov 15;96(9):767-73. doi: 10.1097/TP.0b013e318298fa61.

    PMID: 23759882BACKGROUND
  • Manyalich M, Ricart A, Martinez I, Balleste C, Paredes D, Vilardell J, Avsec D, Dias L, Fehrman-Eckholm I, Hiesse C, Kyriakides G, Line PD, Maxwell A, Nanni Costa A, Paez G, Turcu R, Walaszewski J. EULID project: European living donation and public health. Transplant Proc. 2009 Jul-Aug;41(6):2021-4. doi: 10.1016/j.transproceed.2009.05.021.

    PMID: 19715823BACKGROUND
  • Pruett TL, Tibell A, Alabdulkareem A, Bhandari M, Cronin DC, Dew MA, Dib-Kuri A, Gutmann T, Matas A, McMurdo L, Rahmel A, Rizvi SA, Wright L, Delmonico FL. The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. Transplantation. 2006 May 27;81(10):1386-7. doi: 10.1097/01.tp.0000214976.36526.e3. No abstract available.

    PMID: 16732173BACKGROUND
  • Collier R. Ontario and Manitoba to reimburse expenses for living organ donors. CMAJ. 2008 Jun 3;178(12):1535. doi: 10.1503/cmaj.080704. No abstract available.

    PMID: 18519896BACKGROUND
  • Concejero AM, Chen CL. Ethical perspectives on living donor organ transplantation in Asia. Liver Transpl. 2009 Dec;15(12):1658-61. doi: 10.1002/lt.21930.

    PMID: 19938130BACKGROUND
  • Hippen B, Matas A. Incentives for organ donation in the United States: feasible alternative or forthcoming apocalypse? Curr Opin Organ Transplant. 2009 Apr;14(2):140-6. doi: 10.1097/MOT.0b013e3283295e0d.

    PMID: 19307965BACKGROUND
  • Howell E, Corder L, Dobson A. Out-of-pocket health expenses for Medicaid and other poor and near-poor persons in 1980. Natl Med Care Util Expend Surv B. 1985 Aug;(4):1-52.

    PMID: 10313450BACKGROUND
  • Jotkowitz A. Notes on the new Israeli organ donation law-2008. Transplant Proc. 2008 Dec;40(10):3297-8. doi: 10.1016/j.transproceed.2008.08.128.

    PMID: 19100375BACKGROUND
  • Price D. Living kidney donation in Europe: legal and ethical perspectives--the EUROTOLD Project. Transpl Int. 1994;7 Suppl 1:S665-7. doi: 10.1111/j.1432-2277.1994.tb01468.x.

    PMID: 11271334BACKGROUND
  • Rithalia A, McDaid C, Suekarran S, Norman G, Myers L, Sowden A. A systematic review of presumed consent systems for deceased organ donation. Health Technol Assess. 2009 May;13(26):iii, ix-xi, 1-95. doi: 10.3310/hta13260.

    PMID: 19422754BACKGROUND
  • Rizvi AH, Naqvi AS, Zafar NM, Ahmed E. Regulated compensated donation in Pakistan and Iran. Curr Opin Organ Transplant. 2009 Apr;14(2):124-8. doi: 10.1097/mot.0b013e328326f6ef.

    PMID: 19469028BACKGROUND
  • Rodrigue JR, Crist K, Roberts JP, Freeman RB Jr, Merion RM, Reed AI. Stimulus for organ donation: a survey of the American Society of Transplant Surgeons membership. Am J Transplant. 2009 Sep;9(9):2172-6. doi: 10.1111/j.1600-6143.2009.02741.x. Epub 2009 Jul 16.

    PMID: 19624568BACKGROUND
  • Vlaicu S, Klarenbach S, Yang RC, Dempster T, Garg AX. Current Canadian initiatives to reimburse live organ donors for their non-medical expenses. Can J Public Health. 2007 Nov-Dec;98(6):481-3. doi: 10.1007/BF03405443.

    PMID: 19039887BACKGROUND
  • Sells R. Incentives for organ donation: some ethical issues. Ann Transplant. 2004;9(1):23-4.

    PMID: 15478883BACKGROUND
  • Schulz-Baldes A, Delmonico FL. Improving institutional fairness to live kidney donors: donor needs must be addressed by safeguarding donation risks and compensating donation costs. Transpl Int. 2007 Nov;20(11):940-6. doi: 10.1111/j.1432-2277.2007.00542.x. Epub 2007 Aug 17.

    PMID: 17711405BACKGROUND
  • Wolters HH, Heidenreich S, Senninger N. Living donor kidney transplantation: chance for the recipient--financial risk for the donor? Transplant Proc. 2003 Sep;35(6):2091-2. doi: 10.1016/s0041-1345(03)00675-4.

    PMID: 14529850BACKGROUND

MeSH Terms

Conditions

Renal Insufficiency

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Kimberly A. Gifford, MBA

    American Society of Transplant Surgeons

    PRINCIPAL INVESTIGATOR
  • Judd Kessler, PhD

    Wharton School, University of Pennsylvania

    PRINCIPAL INVESTIGATOR
  • Robert M. Merion, MD, FACS

    Arbor Research Collaborative for Health

    PRINCIPAL INVESTIGATOR
  • Amit K. Mathur, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR
  • Akinlolu O. Ojo, MD, PhD, MBA

    University of Arizona Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2017

First Posted

November 22, 2017

Study Start

November 15, 2017

Primary Completion

June 17, 2020

Study Completion

October 20, 2020

Last Updated

January 3, 2022

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

The study was terminated prior to full enrollment so there are no data to be shared

Locations